HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
Breast Cancer Update
00:00
What a five‑month median PFS means clinically
Hamilton explains PFS distribution—many progress early while responders can achieve durable benefit beyond median.
Play episode from 23:07
Transcript
